3Q23 & 9M23 Performance Overview slide image

3Q23 & 9M23 Performance Overview

Private investment stage portfolio companies EXTERNALLY VALUED 29 CLINICS & DIAGNOSTICS BUSINESS OVERVIEW Outpatient visits per capita, Georgia HIGH GROWTH PROSPECTS IN THE CLINICS BUSINESS Outpatient encounters per capita 2.4 2.1 1.8 1.9 1.9 4.4 3.6 3.5 3.6 3.7 3.2 3.3 3.1 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 Source: NCDC statistical yearbook 2021 MEDIUM TERM OBJECTIVES GEORGIA CAPITAL Government Expenses on Primary Care VS GDP 7.8 5.8 15% 5.7 3.7 4.0 3.5 1.6 Source: WHO 2021 10% 7.6% 6.8% 5% 3.8% 8.2% 12.2% 7.6% 6.8% 0% MDA RUS KAZ TJK ARM UZB GEO Source: WHO 2020 Clinics & Polyclinics Diagnostics › Adding new services > Expansion of retail > Geographic expansion > > Attracting B2B clients Combined financial targets for Clinics and Diagnostics for the next 5-years (2021-2026) DOUBLE DIGIT REVENUE CAGR EBITDA C.GEL 35-40 MILLION + > > Developing distance channels Sustainable growth of clinical & service quality Adding customer base > Improved logistics > JCI and CAP accreditation > Digitalisation 70 70
View entire presentation